|Table of Contents|

Trend analysis on incidence and mortality of brain and nervous system tumors in China from 2005 to 2016

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 11
Page:
2105-2110
Research Field:
Publishing date:

Info

Title:
Trend analysis on incidence and mortality of brain and nervous system tumors in China from 2005 to 2016
Author(s):
XU Lingfeng1FANG Shuowen1REN Xiaoqing1ZHA Zhenqiu2ZHANG Tao2LU Manman1
1.School of Health Management,Anhui Medical University,Anhui Hefei 230032,China;2.Anhui Provincial Center for Disease Control and Prevention,Anhui Hefei 230601,China.
Keywords:
brain and nervous system tumorsincidencemortalitytemporal trendJoinpoint regression analysis
PACS:
R742
DOI:
10.3969/j.issn.1672-4992.2023.11.024
Abstract:
Objective:To provide scientific reference for further optimizing prevention and control strategies by understanding the disease burden and change trend of brain and nervous system tumors in China.Methods:The incidence and mortality data of brain and nervous system tumors in China Cancer Registration Annual Report from 2005 to 2016 were extracted,and the standardized incidence rate and mortality rate of different populations were calculated,and the trends were identified with the Joinpoint regression model.Results:From 2005 to 2016,the standardized incidence rate of brain and nervous system tumors in China,males and females,urban and rural areas showed upward trends,with AAPC of 3.58%,3.15%,4.01%,2.82%and 6.08%,respectively(all P<0.05).There was no significant gender difference in the standardized incidence rate.The overall standardized incidence rate in urban areas(5.65/100 000) was higher than that in rural areas(4.64/100 000).From 2005 to 2016,the standardized mortality of brain and nervous system tumors in China,males and females,urban and rural areas showed significant upward trends,with AAPC of 3.17%,3.08%,3.27%,2.74% and 2.25%,respectively(all P<0.05).The overall standardized mortality rate of males(3.48/100 000) was higher than that of females(2.35/100 000),and that of rural areas(3.19/100 000) was higher than that of urban areas(2.72/100 000).The key population of incidence and mortality was the elderly,among which the peak of incidence and mortality of females and rural population was in the 70~year old group,while the peak of incidence and mortality of males and urban population was in the 75~year old group.Conclusion:The disease burden of brain and nervous system tumors in China is increasing year by year,and the incidence of brain and nervous system tumors in women and rural residents is increasing rapidly.Therefore,the early screening and health intervention in key populations should be strengthened.

References:

[1]杨学军,江涛.解读《世界卫生组织中枢神经系统肿瘤分类(2016年)》[J].中国神经精神疾病杂志,2016,42(06):321-329. YANG XJ,JIANG T.Interpretation of the world health organization classification of central nervous system tumors(2016) [J].Chinese Journal of Neuropsychiatric Disorders,2016,42(06):321-329.
[2]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3]赫捷,魏文强.2019中国肿瘤登记年报[M].北京:人民卫生出版社,2019:193-197. HE J,WEI WQ.2019 China cancer registration annual report [M].Beijing:People's Health Publishing House,2019:193-197.
[4]DEANGELIS LM.Global consequences of malignant CNS tumours:a call to action[J].Lancet Neurol,2019,18(4):324-325.
[5]MORTAZAVI SMJ,MORTAZAVI SAR,PAKNAHAD M.Cancers of the brain and CNS:Global patterns and trends in incidence[J].J Biomed Phys Eng,2018,8(1):151-152.
[6]KIM HJ,FAY MP,FEUER EJ,et al.Permutation tests for joinpoint regression with applications to cancer rates[J].Stat Med,2000,19(3):335-351.
[7]HENLEY SJ,WARD EM,SCOTT S,et al.Annual report to the nation on the status of cancer,part I:National cancer statistics[J].Cancer,2020,126(10):2225-2249.
[8]DEORAH S,LYNCH CF,SIBENALLER ZA,et al.Trends in brain cancer incidence and survival in the United States:Surveillance,Epidemiology,and End Results Program,1973 to 2001[J].Neurosurg Focus,2006,20(4):E1.
[9]MCNEILL KA.Epidemiology of brain tumors[J].Neurol Clin,2016,34(4):981-998.
[10]OSTROM QT,BAUCHET L,DAVIS FG,et al.The epidemiology of glioma in adults:a "state of the science" review[J].Neuro Oncol,2014,16(7):896-913.
[11]VIENNE-JUMEAU A,TAFANI C,RICARD D.Environmental risk factors of primary brain tumors:A review[J].Rev Neurol(Paris),2019,175(10):664-678.
[12]段纪俊,陈万青,杨念念,等.2003-2007年中国脑瘤发病与死亡分析[J].中国肿瘤,2012,21(09):644-649. DUAN JJ,CHEN WQ,YANG NN,et al.Analysis of the onset and death of brain tumors in China from 2003 to 2007[J].Tumor in China,2012,21(09):644-649.
[13]查震球,刘志荣,郑荣寿,等.2008-2012年中国肿瘤登记地区脑及神经系统肿瘤发病与死亡分析[J].中华疾病控制杂志,2018,22(11):1101-1105. ZHA ZQ,LIU ZR,ZHENG RS,et al.Analysis of morbidity and death of brain and nervous system tumors in the tumor registry of China from 2008 to 2012[J].Chinese Journal of Disease Control,2018,22(11):1101-1105.
[14]丁贤彬,吕晓燕,焦艳,等.2012年至2018年重庆市脑及神经系统肿瘤发病死亡趋势分析[J].现代肿瘤医学,2021,29(11):1970-1974. DING XB,LYU XY,JIAO Y,et al.Analysis of the incidence and death trend of brain and nervous system tumors in Chongqing from 2012 to 2018[J].Modern Oncology,2021,29(11):1970-1974.
[15]刘艺敏,朱炎,陈国民,等.上海市虹口区中老年居民自我保健意识状况的调查[J].实用预防医学,2002,30(02):118-120. LIU YM,ZHU Y,CHEN GM,et al.Investigation on the self-health care awareness of middle-aged and elderly residents in Hongkou District,Shanghai[J].Practical Preventive Medicine,2002,30(02):118-120.
[16]GONCALVES PH,PETERSON SL,VIGNEAU FD,et al.Risk of brain metastases in patients with nonmetastatic lung cancer:Analysis of the Metropolitan Detroit Surveillance,Epidemiology,and End Results(SEER) data[J].Cancer,2016,122(12):1921-1927.
[17]ROSTAMI R,MITTAL S,ROSTAMI P,et al.Brain metastasis in breast cancer:a comprehensive literature review[J].J Neurooncol,2016,127(3):407-414.
[18]BENSON VS,KIRICHEK O,BERAL V,et al.Menopausal hormone therapy and central nervous system tumor risk:large UK prospective study and meta-analysis[J].Int J Cancer,2015,136(10):2369-2377.
[19]徐源佑,张永辉,丁璐璐,等.1972-2016年启东市脑肿瘤死亡趋势分析[J].中国慢性病预防与控制,2021,29(03):236-240. XU YY,ZHANG YH,DING LL,et al.Analysis of brain tumor death trend in Qidong during 1972-2016[J].Chronic Disease Prevention and Control in China,2021,29(03):236-240.
[20]PARK KB,JOHNSON WD,DEMPSEY RJ.Global neurosurgery:The unmet need[J].World Neurosurg,2016,88:32-35.
[21]GBD 2016 Brain and Other CNS Cancer Collaborators.Global,regional,and national burden of brain and other CNS cancer,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet Neurol,2019,18(4):376-393.
[22]PIEL C,POUCHIEU C,TUAL S,et al.Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN[J].Int J Cancer,2017,141(9):1771-1782.
[23]BHAT AR,WANI MA,KIRMANI AR.Brain cancer and pesticide relationship in orchard farmers of Kashmir[J].Indian J Occup Environ Med,2010,14(3):78-86.
[24]SONG BB,LIU W,HE H,et al.Analysis and prediction of brain tumor incidence in Nangang District,Harbin[J].Journal of Harbin Medical University,2008,190(04):437-438.
[25]韩仁强,周金意,张思维,等.2015年中国脑瘤发病与死亡分析[J].中国肿瘤,2021,30(01):29-34. HAN RQ,ZHOU JY,ZHANG SW,et al.Analysis of brain tumor onset and death in China in 2015[J].Tumor in China,2021,30(01):29-34.
[26]张宝双,周欢娣,王国辉,等.MGMT启动子甲基化状态与IDH1及1p/19q对脑胶质瘤患者假性进展的诊断价值[J].中国肿瘤临床,2022,49(11):583-587. ZHANG BS,ZHOU HD,WANG GH,et al.Diagnostic value of MGMT promoter methylation status and IDH 1 and 1p/19q for pseudoprogression in glioma patients[J].Clinical Oncology in China,2022,49(11):583-587.
[27]苏天崎,孙阳,梁鹏.基于Logistic回归分析多发脑转移瘤手术后的预后影响因素[J].哈尔滨医科大学学报,2022,56(03):230-233. SU TQ,SUN Y,LIANG P.Based on Logistic regression analysis of multiple outcomes after surgery for brain metastases[J].Journal of Harbin Medical University,2022,56(03):230-233.
[28]闵素梅,殷章红.武汉地区老年脑肿瘤患者生存质量的影响因素分析[J].中国实用神经疾病杂志,2016,19(07):34-36. MIN SM,YIN ZH.Analysis of the quality of survival of elderly brain tumor patients in Wuhan[J].Chinese Journal of Practical Neurological Disorders,2016,19(07):34-36.
[29]DUAN ZH,ZHANG M,XU JR,et al.Trend analysis and prediction of brain tumor deaths in China from 2000 to 2019 [J].General Practice in China,2023,26(06):734-741.
[30]许春.我国人口老龄化现况[J].中国农村卫生事业管理,2021,41(11):823. XU C.The current situation of population aging in China [J].Rural Health Service Management in China,2021,41(11):823.

Memo

Memo:
National Natural Science Foundation of China(No.71804002);国家自然科学基金(编号:71804002)
Last Update: 2023-04-28